PARI Pharma, New Name of PARI Aerosol Research Institute [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

January 3, 2007, Monterey, California

PARI’s eFlow Wins Good Design Award [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

December 4, 2006, Monterey, California

NIH using PARI’s eFlow in HIV/AIDS Vaccine Research [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

November 29, 2006, Monterey, California

PARI’s eFlow in Cystic Fibrosis Clinical Trial of L-arginine [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

November 20, 2006, Monterey, California

PARI and Kamada Collaborate to Develop Inhaled Alpha-1 Antitrypsin [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

October 16, 2006, Monterey, California

PARI’s eFlow Nebulizer used in Alnylam Clinical Trial for Respiratory Syncytial Virus; New Drug Based on RNAi Technology [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

June 19, 2006, Midlothian, Virginia

PARI Named Leading Nebulizer Company in Cambridge Consulting Survey; Market Dominance Also Visible with Frost & Sullivan Award for Product Innovation [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

May 17, 2006, Midlothian, Virginia

PARI Celebrates 100 Years of Aerosol Therapy [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

April 10, 2006. Monterey, California

PARI Pharma receives Medical Design Excellence Award for eFlow Nebulizer [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

April 6, 2006. Gemünden and Munich, Germany

Activaero and PARI combine technologies to create controlled breath nebulizer [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

April 6, 2006.  Biotech Business Week

Related Kamada Press Release [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

January 24, 2006. Monterey, California

PARI Pharma and Kamada to develop Inhaled Emphysema Therapy [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

November 15, 2005. Monterey, California

PARI to present eFlow Development at Medical Plastics Seminar; Discussion of a Customizable Platform for New Inhaled Drug Formulations [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

November 14, 2005. Monterey, California

PARI Issued US Patent for eFlow; Device Innovations Lead to Greater Efficiency in Drug Delivery [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

July 29, 2005. Munich, Germany

PARI’s Inhaled Cyclosporin Granted Orphan Status in EU  [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

October 20, 2004. Monterey, California

PARI Pharma’s Formulation Work and eFlow Featured in Corus Pharma’s Positive Phase II Trial Results -- Marks Greater Headway in Drug/Device Matching [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

August 23, 2004. Monterey, California

PARI Granted Orphan Drug Designation for Inhaled Cyclosporine – Potential New Therapy for Lung Transplant Patients [more]

- - - - - - - - - - - - - - - - - -  - - - - - - - - - - - - - - - -

April 25, 2004. Monterey, California

Corus Pharma’s Phase III Trial for Cystic Fibrosis Drug is First to Feature PARI’s eFlow -- Marks Customization in Drug/Device Matching [more]